Trial ID or NCT#

NCT03176173

Status

recruiting iconRECRUITING

Purpose

This phase II trial studies how well radical-dose image guided radiation therapy works in treating patients with non-small cell lung cancer that has spread to other places in the body who are undergoing immunotherapy. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radical-dose image guided radiation therapy to patients with non-small cell lung cancer may help to improve response to immunotherapy anti-cancer treatment.

Official Title

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Michael Gensheimer
Michael Gensheimer
Radiation oncologist
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
Billy W. Loo, Jr., MD, PhD, DABR
Billy W. Loo, Jr., MD, PhD, DABR
Radiation oncologist, Thoracic specialist
Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center
Joel Neal, MD, PhD
Joel Neal, MD, PhD
Medical oncologist, Thoracic specialist
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Maximilian Diehn, MD, PhD
Maximilian Diehn, MD, PhD
Radiation oncologist
Associate Professor of Radiation Oncology (Radiation Therapy)
Heather Wakelee
Heather Wakelee
Medical oncologist, Thoracic specialist
Professor of Medicine (Oncology) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Kim Nguyen
(650) 497-8966